Tianjin Sega Pharmaceutical Co.,Ltd

Company Description



Tianjin Sega Pharmaceutical Co.,Ltd will attend CPhI China 2011 in Shanghai, China during June 21st-23rd. Booth No.:W1C02. Welcome to visit our booth at appointed time......
......Tianjin Sega Pharmaceutical Co.Ltd,belonging to TianJin Pharmaceutical Holdings(TJPH), is a wholly owned subsidiary company of Tianjin Lisheng Pharmaceutical Co., Ltd. Sega invests 480 million RMB(70 million USD) to construct its APIs manufacturing site, which covers 199 thousand sq meters.As a professional pharmaceutical company, Sega dedicates itself to improving people?? health, providing high-quality pharmaceutical products and relevant service to human being. It applies the latest state of the art technology to manufacture APIs. To ensure the production of high-quality pharmaceuticals, the facilities are built and administered according to the ICH Q7A and  cGMP standard strictly, aiming to make itself approved by the the pharmaceutical administration of the regulatory market, such as US FDA, EDQM, PMDA etc..

Company Information

  • Contact Person:Changfeng.Long
  • Job Title:Sales Manager
  • Telephone:
  • Fax:
  • Business Type:Manufacturer
  • Year Established:2007
  • Number Of Employees:501 - 1000
  • Total Annual Sales Volume:USD 5,000,001 - 10,000,000
  • Main Products:Lamivudine,API,Lamivudine's, HBV,HIV,GMP
  • Address:Tianyu Science and Technology Park, Jinghai, Tianjin, PR China Tianjin Tianjin 301609 China
  • Website:Visit website

Product

  • Lamivudine
  • Emtricitabine
  • Lamivudine API
  • Lamivudine Base API
  • Lamivudine
  • Emtricitabine
  • Lamivudine API
  • Lamivudine
  • Lamivudine Base API
  • Lamivudine
  • Lamivudine Base API
  • Lamivudine Cphi
Countries   China   India   Indonesia   Malaysia   Pakistan   Turkey   United Kingdom   United States   All Countries